ESCRS - FP05.15 - Comparison Of Clinical Outcomes And Visual Quality Between Two Edof Iols: Part 2

Comparison Of Clinical Outcomes And Visual Quality Between Two Edof Iols: Part 2

Published 2025 - 43rd Congress of the ESCRS

Reference: FP05.15 | Type: Free paper | DOI: 10.82333/3m4e-6y45

Authors: Ruben D. Berrospi* 1 , Camilo Angel 2 , Camilo Niño 3 , Alejandro Tello 4 , Virgilio Galvis 5 , Adriana Reyes 6 , Dora Nova 6 , Valeria Otoya 7

1Centro Oftalmológico Virgilio Galvis,Floridablanca,Colombia;Fundación Oftalmologica de Santander,Floridablanca,Colombia;Universidad Autonoma de Bucaramanga,Bucaraanga,Colombia, 2Universidad Autonoma de Bucaramanga,Bucaraanga,Colombia, 3Centro Oftalmológico Virgilio Galvis,Floridablanca,Colombia;Universidad Autonoma de Bucaramanga,Bucaramanga,Colombia, 4Universidad Autonoma de Bucaramanga,Bucaramanga,Colombia;Centro Oftalmológico Virgilio Galvis,Floridablanca,Colombia;Universidad industrial de Santander,Bucaramanga,Colombia, 5Centro Oftalmológico Virgilio Galvis,Floridablanca,Colombia;Fundación Oftalmologica de Santander,Floridablanca,Colombia;Universidad Autonoma de Bucaramanga,Bucaramanga,Colombia, 6Universidad Autonoma de Bucaramanga,Bucaramanga,Colombia, 7Fundación Oftalmologica de Santander,Floridablanca,Colombia

Purpose

The main purpose is to observe the differences in visual quality between Comfort IOL (LS-313 MF 15-Oculentis GmbH, Berlin, Germany) and AcrySoft IQ Vivity at 3-month follow-up. Therefore, to detect differences in visual acuity by far, intermediate and near distances. In addition, to compare contrast sensitivity, photic phenomena, and patient satisfaction at 3 months of follow-up between these two EDOF IOLs.

Setting

This is a prospective, randomized, parallel, single-center study at the Zaldivar Institute in Mendoza, Argentina, during 2023 (half of patients: Part 1) and 2024 (including the rest of patients: Part 2).

Methods

96 eyes (48 patients) between 50 and 70-year-old with presbyopia were selected. 48 eyes (24 patients) were implanted with Vivity EDOF IOLs bilaterally and the remaining with Comfort EDOF IOLs. The measurements were performed preoperatively and postoperatively (1 and 3 months postop). UCVA (uncorrected visual acuity) and BCVA (Best corrected visual acuity) were measured in far (6m), intermediate (67 cm) and near (40 cm) distances. As well as manifest refraction spherical equivalent (MRSE).

Furthermore, contrast sensitivity (Optec® 6500 FACT), pupillometry (Sirius topographer), macula OCT were carried out. Halos-Glare Simulator and Visual Quality questionnaire (QoV) were performed in order to analyze dysphotopsia and patient’s satisfaction.

Results

UCVA improved from 0.69 logMAR preop to 0.07 at 3 months postop in Comfort group and from 0.59 to 0.13 in Vivity group. Intermediate and near vision at 3 months postop were 0.09 logMAR and 0.23 in Comfort, and 0.17 and 0.29 in Vivity, respectively. MRSE changed from +2.00 D to -0.24 D in Comfort and from +1.90 D to -0.18 D in Vivity.

Contrast sensitivity increased by 5.81% in the Comfort, while it decreased by 2.41% in the Vivity. Regarding photic phenomena, in Comfort, 33% of patients reported mild halos, 13% moderate halos, while 54% reported none. In the Vivity group, 30% of patients reported mild halos, 35% moderate halos, and 35% reported none.

77% of patients in the Comfort group reported being very satisfied while 72% in Vivity group.

Conclusions

Both Extended Depth of Focus (EDOF) intraocular lenses (IOLs) demonstrated favorable outcomes in distance and intermediate vision, along with high levels of patient satisfaction. Nonetheless, the Comfort IOL exhibited a marginal superiority over the Vivity IOL concerning photic phenomena and contrast sensitivity.